5q14.3 neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C

Am J Med Genet A. 2011 Jul;155A(7):1640-5. doi: 10.1002/ajmg.a.34059. Epub 2011 May 27.

Abstract

Haploinsufficiency of RASA1, located on chromosome 5q14.3, has been identified as the etiology underlying the disorder capillary malformation-arteriovenous malformation (CM-AVM). Recently, haploinsufficiency of MEF2C, located 1.33 Mb distal to RASA1 on chromosome 5q14.3, has been implicated as the genetic etiology underlying a complex array of deficits including mental retardation, hypotonia, absent speech, seizures, and brain anomalies. Here we report a patient who is haploinsufficient in both RASA1 and MEF2C who presents with dermatologic and neurologic abnormalities that constitute a 5q14.3 neurocutaneous syndrome. This finding highlights the need to assess for CM-AVM in patients with neurologic features consistent with MEF2C haploinsufficiency, and vice versa.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Brain / pathology
  • Child
  • Child, Preschool
  • Chromosome Banding
  • Chromosomes, Human, Pair 5 / genetics*
  • Comparative Genomic Hybridization
  • Gene Deletion*
  • Gene Order
  • Haploinsufficiency
  • Humans
  • Infant
  • Infant, Newborn
  • MADS Domain Proteins / genetics*
  • MEF2 Transcription Factors
  • Magnetic Resonance Imaging
  • Male
  • Myogenic Regulatory Factors / genetics*
  • Neurocutaneous Syndromes / diagnosis
  • Neurocutaneous Syndromes / genetics*
  • Phenotype
  • Skin / pathology
  • p120 GTPase Activating Protein / genetics*

Substances

  • MADS Domain Proteins
  • MEF2 Transcription Factors
  • MEF2C protein, human
  • Myogenic Regulatory Factors
  • RASA1 protein, human
  • p120 GTPase Activating Protein